IC Targets AS
🇳🇴Norway
- Country
- 🇳🇴Norway
- Ownership
- Private
- Established
- 2002-01-01
- Employees
- 1
- Market Cap
- -
- Website
- http://www.ictargets.com
Mangafodipir - an Intracellular Contrast Agent for Magnetic Resonance Imaging (MRI): Measuring Manganese Uptake Rate in Heart Failure Patients With Preserved Ejection Fraction (HFpEF) Patients.
Phase 2
Recruiting
- Conditions
- Interventions
- First Posted Date
- 2024-12-12
- Last Posted Date
- 2024-12-12
- Lead Sponsor
- IC TARGETS AS
- Target Recruit Count
- 42
- Registration Number
- NCT06731738
- Locations
- 🇳🇴
Oslo University Hospital, Department of Cardiology, Rikshospitalet Sognsvannsveien 20, Oslo, Norway
© Copyright 2024. All Rights Reserved by MedPath